Exact Mass: 435.128641
Exact Mass Matches: 435.128641
Found 45 metabolites which its exact mass value is equals to given mass value 435.128641,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cys Cys Asn Pro
Cys Cys Pro Asn
Cys Asn Cys Pro
Cys Asn Pro Cys
Cys Pro Cys Asn
Cys Pro Asn Cys
Asn Cys Cys Pro
Asn Cys Pro Cys
Asn Pro Cys Cys
Pro Cys Cys Asn
Pro Cys Asn Cys
Pro Asn Cys Cys
Lys-Phe4Cl-OH
C20H22ClN3O6 (435.11970620000005)
Phe4Cl-Lys-OH
C20H22ClN3O6 (435.11970620000005)
(DANSYLAMINOETHYL)-TRIMETHYLAMMONIUM PERCHLORATE
C17H26ClN3O6S (435.12307660000005)
fmoc-(r)-3-amino-4-(4-chloro-phenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Fmoc-(R)-3-Amino-4-(3-chloro-phenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Fmoc-(R)-3-Amino-4-(2-chlorophenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Fmoc-(S)-3-amino-4-(3-chloro-phenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Fmoc-(S)-3-Amino-4-(4-chlorophenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Fmoc-(S)-3-Amino-4-(2-chloro-phenyl)-butyric acid
C25H22ClNO4 (435.1237282000001)
Danicamtiv
C16H20F3N5O4S (435.1188036000001)
C78274 - Agent Affecting Cardiovascular System > C78322 - Cardiotonic Agent
N-[5-(Ethylsulfonyl)-2-methoxyphenyl]-5-[3-(2-pyridinyl)phenyl]-1,3-oxazol-2-amine
C23H21N3O4S (435.1252706000001)
2,4-Diamino-6-ethyl-5,3-(2-trifluoromethyl-4-sulphonamidophenoxy)prop-1-yloxypyrimidine
C16H20F3N5O4S (435.1188036000001)
2-[[2-[(2,5-Dimethylphenyl)sulfonylamino]-1-oxoethyl]amino]-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
3-[[4-(4-Fluorophenyl)-1-piperazinyl]sulfonyl]benzoic acid [2-(methylamino)-2-oxoethyl] ester
C20H22FN3O5S (435.12641340000005)
2-[[5-(7-Methoxy-2-benzofuranyl)-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-1-(4-methoxyphenyl)ethanone
C23H21N3O4S (435.1252706000001)
(E)-2-(benzenesulfonyl)-3-[2-(4-methylpiperazin-1-yl)-4-oxopyrido[1,2-a]pyrimidin-3-yl]prop-2-enenitrile
C22H21N5O3S (435.1365036000001)
N-[(7-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-(3-pyridinylmethyl)benzenesulfonamide
C23H21N3O4S (435.1252706000001)
4-chloro-3-[[4-(2,3-dimethylphenyl)-1-piperazinyl]-oxomethyl]-N,N-dimethylbenzenesulfonamide
C21H26ClN3O3S (435.13833160000013)
8-Chloro-10-[3-[4-(2-hydroxyethyl)-1-piperazinyl]propyl]phenothiazine-2,3-diol
C21H26ClN3O3S (435.13833160000013)
2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetaldehyde
Ampreloxetine (TFA)
C20H19F6NO3 (435.1269056000001)
Ampreloxetine (TD-9855) TFA is a potent and orally active norepinephrine (NE) and serotonin 5-HT inhibitor. Ampreloxetine TFA has the potential for the research of neurogenic orthostatic hypotension[1][2].
1-(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-2-phenylacetyl)pyrrolidine-2-carboxylic acid
C24H21NO7 (435.13179560000003)
(2s)-1-{2-[(4e,5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid
C24H21NO7 (435.13179560000003)
1-{2-[(5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-2-phenylacetyl}pyrrolidine-2-carboxylic acid
C24H21NO7 (435.13179560000003)
20,28-dihydroxy-4,11,18,25-tetraazaheptacyclo[14.11.1.0²,¹⁵.0³,¹².0⁵,¹⁰.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-2(15),3,5,7,9,11,13,17,19,21,23,25-dodecaene-9-carboximidic acid
8-[(4,5-dihydroxy-6-methyloxan-2-yl)oxy]-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione
C24H21NO7 (435.13179560000003)
8-{[(2s,4r,5r,6s)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-1-hydroxy-3-methyl-6-azatetraphene-7,12-dione
C24H21NO7 (435.13179560000003)